Use of levosimendan in ICU settings, tuesday september 26, 2017
09:30 – 11:15 CEST

Effects of levosimendan on weaning and on renal function

This series of tutorials is focused on the use of levosimendan in treating patients difficult to wean from ventilator, and on the effects of levosimendan on renal function. The lecturers will comment the existing literature, show new data, and explain how they use levosimendan in their clinical practice. Participants are welcome to interact with the lecturers both after each presentation and during the short panel debate which will follow the three lectures.

9:30 – 10:00  
 
How to treat patients difficult to wean from ventilator.
Stefaan Bouchez - Gent, Belgium
Click here to enter the meeting
10:00 – 10:30  
 
Literature on levosimendan vs experience.
Alain Rudiger - Zürich, Switzerland
Click here to enter the meeting
10:30 – 11:00  
 
Effects of levosimendan on renal function.
Sven-Eric Ricksten - Gothenburg, Sweden
Click here to enter the meeting
Panel debate, Questions & Answers, 15 min
Click here to register
14:00 – 15:45 CEST

Levosimendan in Septic shock

This series of tutorials is focused on the epidemiology and treatment modalities of septic shock. More in detail, the lecturers will explain on which patients and in which clinical settings the use of levosimendan might be beneficial. A brief recap of the existing literature will be followed by clinical cases. Participants are welcome to interact with the lecturers both after each presentation and during the short panel debate which will follow the three lectures.

14:00 – 14:30  
 
Epidemiology.
Tobias Liebregts - Essen, Germany
Click here to enter the meeting
14:30 – 15:00  
 
Treatment modalities.
Massimo Girardis - Modena, Italy
Click here to enter the meeting
15:00 – 15:30  
 
Literature vs experience.
Antoine Herpain - Brussels, Belgium
Click here to enter the meeting
Panel debate, Questions & Answers, 15 min
click here to register
16:00 – 17:45 CEST

Levosimendan in Cardiogenic shock

This series of tutorials is focused on the epidemiology and treatment modalities of cardiogenic shock. More in detail, the lecturers will explain on which patients and in which clinical settings the use of levosimendan might be beneficial. A brief recap of the existing literature will be followed by clinical cases. Participants are welcome to interact with the lecturers both after each presentation and during the short panel debate which will follow the three lectures.

16:00 – 16:30  
 
Epidemiology.
Jesper Kjaergaard - Copenhagen, Denmark
Click here to enter the meeting
16:30 – 17:00  
 
Treatment modalities.
Johann Knotzer - Wels, Austria
Click here to enter the meeting
17:00 – 17:30  
 
Literature vs experience.
Bruno Levy - Nancy, France
Click here to enter the meeting
Panel debate, Questions & Answers, 15 min
click here to register